Skip to main content
Shedir Pharma Group logo

Shedir Pharma Group — Investor Relations & Filings

Ticker · SHE ISIN · IT0005379620 LEI · 81560092B300849E9017 XMIL Manufacturing
Open in API
Filings indexed 124 across all filing types
Latest filing 2019-07-24 Earnings Release
Country IT Italy
Listing XMIL SHE

About Shedir Pharma Group

https://www.shedirpharmagroup.com

Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.

Recent filings

Filing Released Lang Actions
Shedir Pet: in grande crescita la nutraceutica per la salute ed il benessere dei piccoli animali domestici
Earnings Release Classification · 99% confidence The document is explicitly labeled as a "COMUNICATO STAMPA" (Press Release) and contains an 'Oggetto' (Subject) detailing business news: 'Shedir Pet: in grande crescita la nutraceutica per la salute ed il benessere dei piccoli animali domestici'. It discusses business strategy, market growth projections (CAGR), and quotes management regarding expansion plans. This content structure—a formal announcement of business developments, often released to the public and regulatory bodies simultaneously—is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a full financial report (like 10-K or IR) but an announcement of operational news and growth prospects, it fits best as an Earnings Release (ER) if it were quarterly/periodical results, or RNS if it's general news. Given the focus on growth and market segment expansion, it functions as a significant business update. However, since it is not explicitly an earnings summary (ER) but rather a press release about a specific business segment's growth, and it is filed under 'Informazione Regolamentata' (Regulated Information) with a specific ID, it is a general regulatory announcement. Since 'ER' is defined as the *initial announcement of periodical financial results (key highlights only)*, and this is more of a strategic/operational update, the most appropriate general category for significant, non-standardized regulatory news is RNS, or potentially ER if the context implies it accompanies or precedes periodic results. Given the structure and the fact it's a press release announcing business expansion, RNS (Regulatory Filings / General Regulatory Announcements) is the safest classification, as it is a formal, regulated communication that doesn't fit the other specific categories perfectly. FY 2019
2019-07-24 Italian
Inizio delle negoziazioni
Regulatory Filings Classification · 95% confidence The document is a press release announcing the start of trading ('Inizio delle negoziazioni') for Shedir Pharma Group S.p.A. shares on the AIM Italia market. It details the opening price, trading volume, capital structure, and provides a corporate event calendar, including the date for the semi-annual financial report approval. This announcement relates to the company's listing/capital structure change and is a formal regulatory communication (indicated by 'Informazione Regolamentata'). Since it is an announcement related to the capital market debut and subsequent corporate events, it fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS). Given the focus on the listing debut, the associated capital structure details, and the announcement of the listing itself, 'CAP' (Capital/Financing Update) is highly relevant. However, the document structure strongly resembles a standard regulatory disclosure ('Informazione Regolamentata') concerning a significant corporate event (IPO/listing commencement). Since there isn't a specific code for an IPO announcement, and it details financing/capital structure changes related to the listing, CAP is a strong candidate. Alternatively, because it is a formal regulatory notice about a significant event, RNS (Regulatory Filings) is also plausible. Given the explicit mention of capital structure (shares outstanding, greenshoe option) and the debut on the capital market, CAP is the most specific fit among the provided options for an event marking the entry into public trading.
2019-07-23 Italian
Comunicazione internal dealing (rettifica)
Director's Dealing Classification · 100% confidence The document is an official notification from Shedir Pharma Group S.p.A., dated July 23, 2019, regarding 'Comunicazione internal dealing (rettifica)' (Internal Dealing Communication (rectification)). The content explicitly details transactions by a person discharging managerial responsibilities ('PRESIDENTE DEL CONSIGLIO DI AMMINISTRAZIONE' - Chairman of the Board of Directors) and is structured using a standardized template for 'notification and public disclosure of transactions by persons discharging managerial responsibilities'. This directly corresponds to the definition of Director's Dealing (insider trades). The filing type code for Director's Dealing is DIRS.
2019-07-23 Italian
Comunicazione internal dealing
Director's Dealing Classification · 99% confidence The document is an official notification from Shedir Pharma Group S.p.A. dated July 23, 2019. The key field 'Oggetto' (Subject) explicitly states 'Comunicazione internal dealing' (Internal dealing communication). Furthermore, the template title is 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing type code for Director's Dealing is DIRS.
2019-07-23 Italian

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.